ReviewPharmacology & therapeutics2017
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Steven R Whittaker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it